Ben Solomon, MBBS, PhD, FRACP
Medical Oncologist at the Peter MacCallum Cancer Centre in Melbourne, Australia
Clinical Advisor
Ben is a medical oncologist at the Peter MacCallum Cancer Center and Professor at the University of Melbourne where he specialized in thoracic oncology. Ben has been involved in practice-changing lung cancer clinical trials with novel inhibitors of ALK, ROS1, NTRK, BRAF, cMET, RET, and KRAS. He has participated in pivotal trials that led to the registration of drugs including crizotinib, ceritinib, lorlatinib, repotrectinib, and selpercatinib. He has authored more than 200 peer-reviewed publications and has been recognized as a Clarivate Highly Cited Researcher (2019, 2020, 2021, 2022).
Ben was elected to the International Association for the Study of Lung Cancer (IASLC) Board in 2023 and is also a Board member of the Cancer Council of Victoria.